Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
Crossref DOI link: https://doi.org/10.1007/s40119-018-0110-5
Published Online: 2018-05-19
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pozdnyakov, Yuri M.
,
Funding for this research was provided by:
Institut de Recherches Internationales Servier and Servier, Moscow, Russian Federation.
Article History
Received: 28 March 2018
First Online: 19 May 2018